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Pharmacokinetics is very important in target validation and in shifting a lead compound into a drug. It is a cumbersome 
process in clinical research. A quantitative personation based on computed, pharmacokinetics, physicochemical properties, 
ILOGP, drug-likeness, medicinal chemistry friendliness, bioavailability radar and BOILED-Egg for all the synthesized, 6 
novel compounds have been assessed using Swiss ADME. An effective drug can be produced from the physicochemical 
properties discussed in this model. The physicochemical properties of all designed Schiff bases of curcumin have been 
found to be optimal and so, they are perceived to have acceptable oral absorption and adequate permeability. All the 
monomers obeyed the rule of five by Lipinski and the oral bioavailability is accounted worldwide. The desired set of 
monomers have been enhanced by effective ADME screening and molecular simulation methods with Microtubule-
associated protein tau (MAPT) (PDB code: 10636) receptor could represent favourable building blocks as preferable 
chemotherapeutic factor in resistance to Alzheimers disease. 
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Pharmacokinetics (PK) is to examine the time course of 
the absorption, distribution, metabolism and excretion 
(ADME) of a compound, drug or new chemical 
entity (NCE) after its dispensation to the body1.  
Drug discovery process consists of spotting and 
personation of new targets. Drug generation requires not 
only accretion of specific and potent recognition by its 
pharmacodynamic objective, but also effective delivery 
to these selected sites2. Lipinski states that, an orally 
vital drug has no more than two violations of the 
following basis: comparatively < 5 hydrogen bond 
donors (oxygen or nitrogen atoms with more than one 
hydrogen atoms); less than 10 hydrogen bond acceptors 
(nitrogen or oxygen atoms); a molecular mass less than 
500 daltons (Da); and an octanol--water partition3 
coefficient log P not greater than 5. A quantitative 
characterization based on computed pharmacokinetics, 
drug-likeness, physicochemical properties, medicinal 
chemistry friendliness BOILED-Egg, ILOGP and 
bioavailability radar for all synthesized 6 novel 
compounds have been evaluated using Swiss ADME4. 
Apart from these physicochemical properties, the 
number of rotatable bonds (RBs) in a molecule has also 
been shown to be important for drug assimilation5. 
Among the aforementioned physicochemical properties, 
lipophilicity has been accredited as a prime factor for a 
drug’s buoyant passage via clinical development and on 
to the marketplace.  
Curcumin and schiff base novel compounds are of 
specific passion because they are sparky compounds 
in the biological field6-8. Several chromone analogues 
have been reported to act as anticancer, anti-HIV, 
antibacterial, anti-inflammatory agents9-18 and also 
act as an efficient agents in the treatment of cystic 
fibrosis19,20, kinase inhibitors, etc. However, there has 
not been examples of polymer synthesis using curcumin 
as a monomer itself. Herein, we have prepared novel 
monomers bearing 4-arylidene curcumin units in their 
main chain. A thorough literature survey reveals that 
several structural modifications have been made in 
poly (azomethine) ester’s backbone21. Among these 
modifications, the synthesis of polyesters using 
symmetrical diol monomers consisting of chromone 
and 4-arylidene curcumin units as backbone has not 
yet been reported in literature. 
Experimental Section 
All the chemicals and reagents were of analytical 
grade and purchased from Alfa Aesar, SRL chemicals, 
and Sigma Aldrich solvents viz. chloroform (SRL 
chemicals), methanol and ethanol (Finar Chemicals 
laboratory) were purified according to standard 
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procedures. FT-IR spectra of the monomers were 
recorded using a PerkinElmer FT IR spectrophotometer 
in the range of 4000-400 cm-1. 1H-NMR spectra of the 
monomers were recorded on the FT-NMR-400 MHz 
spectrophotometer (ATR mode) using DMSO-d6  
or CDCl3 as a solvent. The absorption spectra were 
recorded with the Agilent 8453 UVeVis diode-array 
spectrophotometer. To screening the ADME properties 
of the monomers within the Swiss using ADME tool. 
Synthetic methods  
A series of chromone based schiff base diol 
monomers were synthesized as shown in Scheme 1. In 
the first step, the compound (1) resorcinol was treated 
with acetic acid in the presence of zinc chloride to get 
compound (2). The Vilsmeier-Haack formylation 
reaction using compound (2), POCl3 and DMF yielded 
7-hydroxy-4H-chromone-3-carbaldehyde (3) in good 
yield22. Finally, the reaction between compound (3) and 
diaminomaleonitrile in methanol at reflux condition 
afforded the chromone based schiff base diol monomer 
(M1).  
The other Schiff base diol monomers M2, M3 & M4 
were prepared using (a) 4-hydroxy benzaldehyde , (b) 
vanillin and (c) isovanillin, respectively in the place 
of compound (3) as in the procedure aforementioned. 
Structurally different curcumin based monomers were 
synthesized as depicted in Scheme 2. Here, curcumin 
was made to react with 4-methoxy-benzaldehyde or 3, 5-
diflurobenzaldehyde in the presence of piperidine 
catalyst in the medium of mixture of methanol and 
chloroform for 48 hours to obtain 4-methoxy arylidene 
curcumin based diol monomer (M5) or 3, 5-difluro 
arylidene based diol monomer (M6). 
Pharmacokinetic studies  
Six novel monomers were effectively designed and 
put through a theoretical in-silico ADME prediction 
using the web tool, Swiss ADME. The 2D structures 
of the designed monomers which had been converted 
Scheme 1 — Synthesis of schiff base diol monomers (M1–M4). 
Scheme 2 — Synthesis of 4-arylidene curcumin based diol monomers (M5, M6). 
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to canonical SMILES format were used to assess the 
ADME properties within the Swiss ADME tool. 
Bioavailability radar plot gives us a graphical insight 
on drug-likeness decisions based on the bioavailability 
index. 
Molecular docking studies 
Molecular docking studies were carried out using the 
Auto Dock Tools version 1.5.6 and Auto Dock version 
4.2.5.1 docking program. The energy predictions were 
formulated using genetic algorithms. The three-
dimensional X-ray structure of microtubule-associated 
protein tau (MAPT) (PDB code: 10636) was offloaded 
from protein data bank (http://www.pdb.org) and the 
anatomy of monomers (M1 to M6) was portrayed by 
CHEMSKETCH and changed into PDB format from 
mol format with OPENBABEL. 
Results and Discussion 
Spectral characterization 
FT IR spectra of monomers (M1-M4), showed strong 
absorptions between 1621–1660 cm-1 which indicate the 
presence of CH=N (azomethine) group and the 
stretching vibrations of pyrone ring carbonyl (C=O) 
group at 1609 cm-1. The presence of C≡N and OH 
groups absorption were observed at 2236–2200 cm-1 & 
3510–3262 cm-1, respectively for schiff based backbone 
monomers. The FT-IR spectra of structurally different 
curcumin based monomers (M5, M6) the stretching 
vibrations of C=O groups exhibited at 1627-1624 cm-1. 
The presence of arylidene CH stretching absorption 
showed at 962 and 965 cm-1, respectively. Fig 1.  
In 1H NMR spectra of compounds M1-M4 (Fig. 
(2A, 2B, 3A & 3B)), signals that appear among 9.79-
9.1 ppm, 10.90-9.77 ppm, and 8.38 ppm indicated the 
presence of azomethine proton, phenolic OH proton 
and pyrone ring proton, respectively. The signal at 
6.77–8.50 ppm was due to the aromatic ring protons 
of monomers.  
Fig. 2A — 1HNMR Spectra of Schiff base monomer- M1; 2B
1HNMR spectra of schiff base monomer- M3 
Fig. 3A—1HNMR spectra of 4-arylidine monomer- M5; 3B
1HNMR spectra of 4-arylidine monomer- M6. 
Fig. 1 — FT IR spectrum of schiff base monomers; M1-M4 and
curcumin monomers: M5, M6  
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The oxymethylene (–OCH3) protons of M3, M5
and M6 compounds signal appeared in the range at 
3.83–3.87 ppm. 
Physicochemical properties  
The physicochemical assets of a drug have a 
remarkable effect on the pharmacokinetic and 
metabolic fate in the body. The results observed 
from Table 1 convey that all the monomers obey the 
Lipinski rule of five. All the monomers have less than 
10 rotatable bonds and thus satisfied the benchmark 
for oral bioavailability. The synthesized monomers 
have log p values ≤ 5 and so, they are predicted to 
have acceptable oral absorption and good permeability. 
The lower the permeability lower is the lipophilicity. 
The reduction in log p increases the compound 
stability. The synthesized monomers discern to have a 
high intestinal absorption excluding the monomer M1 
which has low GI absorption and high TPSA, and 
could pervade quite easily over the intestinal face of 
the cell membrane. Drugs need to travel through the 
blood brain barrier (BBB) to reach their goal. It is 
perceived from the Table 2 that all the monomers do 
not penetrate into BBB and accordingly do not 
influence the CNS. From Table 2, it is seen that M6 
has the least negative value and thus it is more skin 
permeant. M1 has more negative log kp value and 
least is the skin permeant. From Table 3, it is noticed 
that there is zero violation to Lipinski for all the 
monomers from M1 to M6 and the monomer M1 has 
1 violation to Veber (TPSA >140) and 1 violation 
with Egan (TPSA > 131.6). The Abbot bioavailability 
score depends on the total charge, TPSA and 
negligence to Lipinski rule explains four classes of 
monomers with possibilities of 11%, 17%, 56%, 85%. 
The data from Table 3, shows that the monomers 
possess bioavailability score (BAS) of 55% and so, 
they are good oral drug candidate. 
Cons. LogP – Consensus LogP, L- Lipinski, V- Veber, 
E- Egan, BAS- Bioavailability Score. SA– Synthetic
Accessibility
Boiled egg representation 
The brain or intestinal estimate D penetration 
method (BOILED-Egg) is the intuitive technique to 
appraise the passive gastrointestinal absorption (HIA) 
and brain penetration (BBB) apropus WLOGP-
versus-TPSA. The white region (yolk) of the egg 
showed high possibility of submissive absorption by 
the gastrointestinal tract and the yellow region (yolk) 
was of high likeness towards brain penetration. The 
monomers 1b, 1c, 1d, 2a and 2b lie in white region 
Table 1 — Physicochemical properties. 
Monomers MW #Rotatable bonds TPSA ESOL Class iLOGP
M1 452.38 4 173.18 Moderately soluble 2.72
M2 316.31 4 112.76 Soluble 2.15
M3 376.37 6 131.22 Soluble 2.71
M4 376.37 6 131.22 Soluble 2.71
M5 486.51 10 102.29 Moderately soluble 4.2
M6 492.47 9 93.06 Poorly soluble 3.47
Table 2 — Permeability effect of the compound. 
Monomers GI absorption BBB permeant iLOGP log Kp (cm/s) 
M1 Low No 2.72 -7.7
M2 High No 2.15 -6.63
M3 High No 2.71 -7.04
M4 High No 2.71 -7.04
M5 High No 4.2 -5.5
M6 High No 3.47 -5.38
Table 3 — Drug likeness and medicinal chemistry properties. 
Molecules 
Lipophilicity Druglikeness Medicinal chemistry
iLOGP XLOGP3 WLOGP MLOGP Cons logP 





L V E Pains Brenk 
M1 2.72 1.91 3.11 -1.96 2.03 0 1 1 0.55 0 2 1 3.86 
M2 2.15 2.25 2.89 0.18 2.16 0 0 0 0.55 0 2 0 3.05 
M3 2.71 2.19 2.91 -0.41 2.18 0 0 0 0.55 0 2 1 3.32 
M4 2.4 2.19 2.91 -0.41 2.12 0 0 0 0.55 0 2 1 3.32 
M5 4.2 5.3 4.75 2.31 4.46 0 0 0 0.55 0 3 3 3.6 
M6 3.47 5.53 5.86 3.38 4.95 0 0 0 0.55 0 3 3 3.48 




and 1a was out of range of the plot (Fig. 4). Monomer 
M1 was not absorbed and not influenced by brain 
(outside the Egg), monomers M2, M3, M4, M5 and 
M6 were well-absorbed but not accessing the brain  
(in the white). In this connection, if the monomer was 
speculated as brain-permeant (in the yolk) was not 
directed to active efflux. 
 
Bioavailability radar  
Bioavailability radar plot gave us graphical insight 
on drug-likeness decisions based on the bioavailability 
index (Fig. 5).  
The pink coloured area is the acceptable 
physiochemical room for oral bioaccessibility and the 
radar has to drop entirely in the pink zone and is 
observed to be drug-like23. The optimal range of each 
of the property in the pink area: LIPO (Lipophilicity): 
-0.7 < XLOGP 3 < +5.0; SIZE: 150g/mol < MW < 
500 g/mol; POLAR (polarity):20Å2< TPSA < 130Å2; 
INSOLU (Insolubility): 0 < Log S (ESOL) < 6; 
INSATU (Insaturation): 0.25 <Fraction of Csp3 < 1; 
FLEX (Flexibility): 0 < Num. rotatable bonds < 9. 
 
Molecular docking studies of monomers 
The docking outcomes are shown in Table 4. All 
the monomers have been deeply coherent into the 
active site of the receptor (Fig. 6). The monomers M2, 
M3, M5, & M6 are possessed higher binding energy 
and observe to have lesser affinity for binding  
with protein targeted and accordingly showed  
weak inhibition effect on the organism. The ligand 
molecules and the receptor have lower relative 
binding energy, so more effective is the binding 
affinity. The results accomplished from molecular 
docking studies spotlight that the interaction between 
the curcumin and schiff base diol monomers and  
the protein target is vanquished by strong hydrogen 
bonding, hydrophobic forces and π- interactions.  
The molecular docking pattern thus, proposes  
the following monomers M1 and M4 among the  
6 monomers as the most propitious to bind with 









Fig. 5 — Bioavailability radar. 
 
Fig. 6 — Molecular simulations of monomersM1, M2, M3, M4, 5,
M6 with the receptor MAPT. 
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Conclusion 
Synthesized 6 novel functional monomers of 
schiff base and curcumin have been exposed to 
in-silico computation of ADME properties using 
Swiss ADME tool. The complete sets of monomers 
have moderate water solubility and consequently 
have good oral absorption and bioavailability. The 
gastro-intestinal absorption observed for the 
monomers are high and there is no effect of toxicity at 
CNS level, owing to non-permeation across the 
blood-brain barrier. The log P rates of all designed 
schiff base and curcumin monomers are optimal and 
consequently have good permeability and oral 
absorption. The docking results accomplish that the 
monomers display fine interaction deep inside the 
receptor sites and revealed bonding and non-bonding 
interactions with the active residues of the MAPT 
receptor. Based on the structure, relationship activity 
of the monomers M1 and M4 shows higher docking 
score. It reveals that the electron withdrawing pyrone 
ring in the moiety enhances the reactivity of monomer 
M1, whereas the methylene substitution which 
the reactivity of monomer M4. The schiff base 
monomers M1 and M4 show tough binding affinity to 
the MAPT and can act as a powerful inhibitor 
against the organism. The desired set of monomers 
has been enhanced by effective ADME screening 
and molecular simulation methods can represent 
favourable building blocks as better chemotherapeutic 
factor in resistance to Alzheimer’s disease. 
These studies however help the medicinal chemists to 
focus on this drug discovery towards the detection of 
antimycobacterial drugs with upraised repressive 
potencies. 
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Table 4 — Molecular docking parameters of monomers (M1-M6) with MAPT. 
Complexes Docking score 
kcal.mol-1 
Active sites with a mode of interaction 
H-bond π-π stacking Hydrophobic contacts 
(Cutoff at 5Å) 
M1 -4.078 ARG A:6 
SER B:27 
-- PRO 8, ALA 26, VAL 4, VAL 5, SER 27, THR 24, SER 3, 
M2 -2.996 GLU B:30 TRP B:29 
TYR B:18 
PRO 8, PRO 9, VAL 17, TRP 29, PRO 12, TYR 18, MET 10, TYR 19. 
M3 -2.968 -- TYR B:18 
TRP B:29 
TYR 19, MET 10, TYR 18, TRP 29, PRO 9, PRO 12, PRO 8, VAL 17,. 
M4 -3.181 TRP B:29 
GLU B:30 
TRP B:29 PRO 9, PRO 8, TRP 29, VAL 17, MET 10, TYR 18, TYR 19, 
M5 -1.865 TRP B:29 
TYR B:18 
-- TRP 6, PRO 32, PRO 8, TRP 29, PRO 9, VAL 7, TYR 18, PRO 12, 
M6 -2.994 LYS A:1 
ARG B:9 
MET B:10 
-- VAL 17, MET 10, VAL 4, ALA 26, VAL 5, PHE 20, VAL 2, 
